-
Needham & Company LLC Reaffirms "Buy" Rating for Stoke Therapeutics (NASDAQ:STOK)
Source: Buzz FX / 19 Mar 2025 12:51:17 America/New_York
Needham & Company LLC Reaffirms "Buy" Rating for Stoke Therapeutics (NASDAQ:STOK) Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Stoke Therapeutics ( NASDAQ:STOK - Get Free Report ) 's stock had its "buy" ra
Read more...